fda semaglutide warning september 2025 The has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Compounded "semaglutide" is not FDA-approved

Diet and lifestyle changes can support your results and help you maintain them, but any decision about stopping or adjusting medication needs to be made with your prescribing clinician, not based on a diet approach alone.

Spread your protein intake evenly throughout the day, rather than consuming a large portion at a single meal

Transforming growth factor beta (TGF-) stimulates myofibroblast differentiation in renal fibrosis [116]

Using real-world data to strengthen GLP-1 treatment and commercial outcomes Digital companions not only support patients but also offer pharmaceutical manufacturers valuable real-world data (RWD) which gets them closer to the patient

M.ShinY

Most side effects resolve within 1-4 weeks as your body adjusts